OtherCELLULAR AND MOLECULAR
Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
Amadeu Gavaldà, Montserrat Miralpeix, Israel Ramos, Raquel Otal, Cristina Carreño, Marisa Viñals, Teresa Doménech, Carla Carcasona, Blanca Reyes, Dolors Vilella, Jordi Gras, Julio Cortijo, Esteban Morcillo, Jesús Llenas, Hamish Ryder and Jorge Beleta
Journal of Pharmacology and Experimental Therapeutics November 2009, 331 (2) 740-751; DOI: https://doi.org/10.1124/jpet.109.151639
Amadeu Gavaldà
Montserrat Miralpeix
Israel Ramos
Raquel Otal
Cristina Carreño
Marisa Viñals
Teresa Doménech
Carla Carcasona
Blanca Reyes
Dolors Vilella
Jordi Gras
Julio Cortijo
Esteban Morcillo
Jesús Llenas
Hamish Ryder
In this issue
OtherCELLULAR AND MOLECULAR
Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
Amadeu Gavaldà, Montserrat Miralpeix, Israel Ramos, Raquel Otal, Cristina Carreño, Marisa Viñals, Teresa Doménech, Carla Carcasona, Blanca Reyes, Dolors Vilella, Jordi Gras, Julio Cortijo, Esteban Morcillo, Jesús Llenas, Hamish Ryder and Jorge Beleta
Journal of Pharmacology and Experimental Therapeutics November 1, 2009, 331 (2) 740-751; DOI: https://doi.org/10.1124/jpet.109.151639
OtherCELLULAR AND MOLECULAR
Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
Amadeu Gavaldà, Montserrat Miralpeix, Israel Ramos, Raquel Otal, Cristina Carreño, Marisa Viñals, Teresa Doménech, Carla Carcasona, Blanca Reyes, Dolors Vilella, Jordi Gras, Julio Cortijo, Esteban Morcillo, Jesús Llenas, Hamish Ryder and Jorge Beleta
Journal of Pharmacology and Experimental Therapeutics November 1, 2009, 331 (2) 740-751; DOI: https://doi.org/10.1124/jpet.109.151639
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement